Ranolazine
Other Cardiac Preparations
Sold as CORZYNA · Ranexa (previously Latixa)
- Drug class
- Other Cardiac Preparations
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 4
- Products on record
- 70
- FDA reports (12 mo)
- 581
Overview
Ranolazine is an active pharmaceutical ingredient in the Other Cardiac Preparations group (C01EB). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 61 | May 29, 2026 |
| US United States | FDA | 3 | May 6, 2026 |
| EU European Union | EMA | 1 | April 10, 2024 |
| CA Canada | Health Canada | 5 | May 6, 2026 |
GBUnited Kingdom· MHRA
61 products
Uses
Ranolazine is indicated in adults as an add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).
How to take
USUnited States· FDA
3 products
Uses
1 INDICATIONS AND USAGE Ranolazine extended-release tablet is indicated for the treatment of chronic angina. Ranolazine extended-release tablet may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.
Ranolazine extended-release tablet is an antianginal indicated for the treatment of chronic angina. ( 1 )
How to take
EUEuropean Union· EMA
1 product
Uses
Ranexa is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).
How to take
CACanada· Health Canada
5 products
5 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [4].
Brands in Canada (1)
Drug interactions
Known interactions involving Ranolazine. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 509. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL001421296 · revised May 15, 2026
- [2]FDA DailyMed · 00979fb3-d70f-49… · revised January 29, 2026 [PDF]
- [3]European Medicines Agency · EMEA/H/C/000805 · revised April 10, 2024
- [4]Health Canada (DPD) · 02510219 · revised July 30, 2025
- [5]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.